PDS Biotechnology Corp — Director's Dealing 2023

Jul 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2023-07-14

Reporting Person: Glover Stephen C. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-14	Employee Stock Option (Right to Buy)	$5.13	A	9000	Acquired	2033-07-14	Common Stock (9000)	Direct

Footnotes

F1: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.